title: New therapeutic aspects of inflammatory cardiomyopathy.
abstract: Inflammatory cardiomyopathy is a term used for left ventricular systolic dysfunction associated with myocarditis. In order to establish definitely the diagnosis, an endomyocardial biopsy (EMB) must be performed. Based on the results of EMB analysis, specific treatment may be added to conventional heart failure therapy. Immunosuppressive therapy in patients with non-viral inflammatory cardiomyopathy has been shown to be effective, and there is also some evidence that antiviral or antimicrobial therapy may be beneficial.
authors.forename: Petr
authors.initials: P
authors.lastname: Kuchynka
authors.forename: Tomas
authors.initials: T
authors.lastname: Palecek
authors.forename: Eduard
authors.initials: E
authors.lastname: Nemecek
authors.forename: Michal
authors.initials: M
authors.lastname: Fikrle
authors.affiliation: 2nd Department of Medicine - Department of Cardiovascular Medicine, General University Hospital in Prague, First Faculty of Medicine, Charles University in Prague, U Nemocnice 2, 128 08 Prague 2, Czech Republic. tpalec@lf1.cuni.cz.
authors.forename: Ales
authors.initials: A
authors.lastname: Linhart
mesh_terms: D001706:Biopsy; D009202:Cardiomyopathies / Q000175:diagnosis / Q000188:drug therapy*; D022062:Electrophysiologic Techniques, Cardiac; D004699:Endocardium / Q000503:physiopathology; D006801:Humans; D007249:Inflammation / Q000175:diagnosis / Q000188:drug therapy; D008279:Magnetic Resonance Imaging